These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15479493)

  • 1. Absence of a correlation of androgen receptor gene CAG repeat length and prostate cancer risk in an African-American population.
    Gilligan T; Manola J; Sartor O; Weinrich SP; Moul JW; Kantoff PW
    Clin Prostate Cancer; 2004 Sep; 3(2):98-103. PubMed ID: 15479493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China.
    Hsing AW; Gao YT; Wu G; Wang X; Deng J; Chen YL; Sesterhenn IA; Mostofi FK; Benichou J; Chang C
    Cancer Res; 2000 Sep; 60(18):5111-6. PubMed ID: 11016637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
    Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial variation in CAG repeat lengths within the androgen receptor gene among prostate cancer patients of lower socioeconomic status.
    Bennett CL; Price DK; Kim S; Liu D; Jovanovic BD; Nathan D; Johnson ME; Montgomery JS; Cude K; Brockbank JC; Sartor O; Figg WD
    J Clin Oncol; 2002 Sep; 20(17):3599-604. PubMed ID: 12202660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset.
    Hardy DO; Scher HI; Bogenreider T; Sabbatini P; Zhang ZF; Nanus DM; Catterall JF
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4400-5. PubMed ID: 8954049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.
    Hsing AW; Chokkalingam AP; Gao YT; Wu G; Wang X; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Chiang T; Chen YL; Stanczyk FZ; Chang C
    Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):337-41. PubMed ID: 11927493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CAG trinucleotide repeat length in the androgen receptor does not predict the early onset of prostate cancer.
    Mir K; Edwards J; Paterson PJ; Hehir M; Underwood MA; Bartlett JM
    BJU Int; 2002 Oct; 90(6):573-8. PubMed ID: 12230620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of the CAG repeat polymorphism of the androgen receptor gene in prostate cancer progression.
    Nam RK; Elhaji Y; Krahn MD; Hakimi J; Ho M; Chu W; Sweet J; Trachtenberg J; Jewett MA; Narod SA
    J Urol; 2000 Aug; 164(2):567-72. PubMed ID: 10893645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor CAG repeat polymorphism in prostate cancer from a Brazilian population.
    Santos ML; Sarkis AS; Nishimoto IN; Nagai MA
    Cancer Detect Prev; 2003; 27(5):321-6. PubMed ID: 14585317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor gene polymorphism and prostate cancer in Taiwan.
    Huang SP; Chou YH; Chang WS; Wu MT; Yu CC; Wu T; Lee YH; Huang JK; Wu WJ; Huang CH
    J Formos Med Assoc; 2003 Oct; 102(10):680-6. PubMed ID: 14691592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GGN repeat length and GGN/CAG haplotype variations in the androgen receptor gene and prostate cancer risk in south Indian men.
    Vijayalakshmi K; Thangaraj K; Rajender S; Vettriselvi V; Venkatesan P; Shroff S; Vishwanathan KN; Paul SFD
    J Hum Genet; 2006; 51(11):998-1005. PubMed ID: 16969583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphic CAG and GGC repeat lengths in the androgen receptor gene and prostate cancer risk: analysis of a Brazilian population.
    Silva Neto B; Koff WJ; Biolchi V; Brenner C; Biolo KD; Spritzer PM; Brum IS
    Cancer Invest; 2008 Feb; 26(1):74-80. PubMed ID: 18181049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer.
    Giovannucci E; Stampfer MJ; Krithivas K; Brown M; Dahl D; Brufsky A; Talcott J; Hennekens CH; Kantoff PW
    Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3320-3. PubMed ID: 9096391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen receptor gene CAG repeat length varies in a race-specific fashion in men without prostate cancer.
    Sartor O; Zheng Q; Eastham JA
    Urology; 1999 Feb; 53(2):378-80. PubMed ID: 9933058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CAG polymorphic repeat lengths in androgen receptor gene among Japanese prostate cancer patients: potential predictor of prognosis after endocrine therapy.
    Suzuki H; Akakura K; Komiya A; Ueda T; Imamoto T; Furuya Y; Ichikawa T; Watanabe M; Shiraishi T; Ito H
    Prostate; 2002 May; 51(3):219-24. PubMed ID: 11967956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen receptor CAG polymorphism and prostate cancer risk.
    Mononen N; Ikonen T; Autio V; Rökman A; Matikainen MP; Tammela TL; Kallioniemi OP; Koivisto PA; Schleutker J
    Hum Genet; 2002 Aug; 111(2):166-71. PubMed ID: 12189490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk.
    Stanford JL; Just JJ; Gibbs M; Wicklund KG; Neal CL; Blumenstein BA; Ostrander EA
    Cancer Res; 1997 Mar; 57(6):1194-8. PubMed ID: 9067292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case-control study of the androgen receptor gene CAG repeat polymorphism in Australian prostate carcinoma subjects.
    Beilin J; Harewood L; Frydenberg M; Mameghan H; Martyres RF; Farish SJ; Yue C; Deam DR; Byron KA; Zajac JD
    Cancer; 2001 Aug; 92(4):941-9. PubMed ID: 11550169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in CAG and GGN repeat lengths and CAG/GGN haplotype in androgen receptor gene polymorphism and prostate carcinoma in Nigerians.
    Akinloye O; Gromoll J; Simoni M
    Br J Biomed Sci; 2011; 68(3):138-42. PubMed ID: 21950206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk.
    Bratt O; Borg A; Kristoffersson U; Lundgren R; Zhang QX; Olsson H
    Br J Cancer; 1999 Oct; 81(4):672-6. PubMed ID: 10574254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.